Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
Figure 5
5-year disease-free survival rate of wild type and mutant K-ras gene in patients received chemotherapy after rejecting Ahnen 1998.